uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Oligonucleotide gap-fill ligation for mutation detection and sequencing in situ.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology.
Show others and affiliations
2015 (English)In: Nucleic Acids Research, ISSN 0305-1048, E-ISSN 1362-4962, Vol. 43, no 22, e151Article in journal (Refereed) Published
Abstract [en]

In clinical diagnostics a great need exists for targeted in situ multiplex nucleic acid analysis as the mutational status can offer guidance for effective treatment. One well-established method uses padlock probes for mutation detection and multiplex expression analysis directly in cells and tissues. Here, we use oligonucleotide gap-fill ligation to further increase specificity and to capture molecular substrates for in situ sequencing. Short oligonucleotides are joined at both ends of a padlock gap probe by two ligation events and are then locally amplified by target-primed rolling circle amplification (RCA) preserving spatial information. We demonstrate the specific detection of the A3243G mutation of mitochondrial DNA and we successfully characterize a single nucleotide variant in the ACTB mRNA in cells by in situ sequencing of RCA products generated by padlock gap-fill ligation. To demonstrate the clinical applicability of our assay, we show specific detection of a point mutation in the EGFR gene in fresh frozen and formalin-fixed, paraffin-embedded (FFPE) lung cancer samples and confirm the detected mutation by in situ sequencing. This approach presents several advantages over conventional padlock probes allowing simpler assay design for multiplexed mutation detection to screen for the presence of mutations in clinically relevant mutational hotspots directly in situ.

Place, publisher, year, edition, pages
2015. Vol. 43, no 22, e151
National Category
Clinical Laboratory Medicine Basic Medicine
Research subject
Pathology
Identifiers
URN: urn:nbn:se:uu:diva-279075DOI: 10.1093/nar/gkv772ISI: 000371237600003PubMedID: 26240388OAI: oai:DiVA.org:uu-279075DiVA: diva2:907498
Funder
Swedish Research CouncilVINNOVAEU, FP7, Seventh Framework Programme, 259796
Available from: 2016-02-29 Created: 2016-02-29 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

fulltext(4186 kB)140 downloads
File information
File name FULLTEXT01.pdfFile size 4186 kBChecksum SHA-512
605bacf436b16d3ed1bdb36f3278dfefc8aa91a6bdb19925c2062947a6a1dbd5bac5b42a2f1844842fff70f2c8060744f86bac532c22f6af5d2d584fc4c8a05d
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

La Fleur, LinneaBotling, JohanLarsson, Chatarina

Search in DiVA

By author/editor
La Fleur, LinneaBotling, JohanLarsson, Chatarina
By organisation
Department of Immunology, Genetics and Pathology
In the same journal
Nucleic Acids Research
Clinical Laboratory MedicineBasic Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 140 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 492 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf